Differentiate intra cellular components associated cancer progression and metastases development.

About

We are developing a multiplex antibody platform capable of monitoring a single binding event. Such single molecule detection is being validated in circulating tumour cell applications where it can differentiate intra cellular components associated cancer progression and metastases development. The patented platform technology has further applications in infectious disease testing and other settings that require multiplex diagnostics. We are is keen to hear form potential collaborators. When contacting us, please quote reference number 5012.

Register for free for full unlimited access to all innovation profiles on LEO

  • Discover articles from some of the world’s brightest minds, or share your thoughts and add one yourself
  • Connect with like-minded individuals and forge valuable relationships and collaboration partners
  • Innovate together, promote your expertise, or showcase your innovations